Successful antipsychotic dose tapering leading to better cognition in patients with remitted psychosis: Results of Guided Antipsychotic Reduction to Reach Minimum Effective Dose (GARMED) trial
Lowering antipsychotic dosage may ameliorate patient performance in several cognitive domains. This finding is worthy of consideration while evaluating the risk-to-benefit ratio of tapering antipsychotics in patients with remitted psychosis.
Authors
- Chih‐Min Liu (ORCID: https://orcid.org/0000-0001-7016-8990)
- Tzung‐Jeng Hwang (ORCID: https://orcid.org/0000-0001-7894-9484)
- Wei‐Li Chen (ORCID: https://orcid.org/0000-0002-1538-2414)
- Ko Yen
- Chen‐Chung Liu (ORCID: https://orcid.org/0000-0002-9290-110X)
- Ming H. Hsieh (ORCID: https://orcid.org/0000-0002-3585-7843)
- Yi‐Ting Lin (ORCID: https://orcid.org/0000-0003-3821-4744)
- Chun-I Liu (ORCID: https://orcid.org/0000-0001-6996-1940)
Institutions
- National Taiwan University (TW)
- National Taiwan University Hospital (TW)
Publication Details
- Journal
- Psychological Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/s0033291725101591
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00